Ataxia with oculomotor apraxia type 1, abbreviated AOA1 and also called early-onset ataxia with ocular motor apraxia and hypoalbuminemia, is a rare autosomal recessive disorder caused by mutations in the APTX gene. It usually begins with uncoordinated movements and ataxia at about age four, though onset can fall anywhere between two and ten. Affected people go on to develop oculomotor apraxia, dysarthric speech, myoclonic jerks, chorea, cognitive impairment and neuropathy, and most start using a wheelchair more than eleven years after onset. Blood tests can show raised cholesterol and creatine kinase and lowered albumin. The APTX gene codes for the protein aprataxin, which may help repair DNA. The disorder is most common in Japan and Portugal, and diagnosis is confirmed by genetic testing.
Facts
Classification
ICD-10 ChapterVI: Diseases of the Nervous System 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) First Described Sources
1. Ataxia with oculomotor apraxia type 1 (Wikipedia)
Lead
uncoordinated movements and ataxia
Lead [causative-agent-category]
caused by mutations in the APTX gene
Lead [disease-category]
rare autosomal recessive disorder
lead sentence 1
Ataxia with oculomotor apraxia type 1 (AOA1), also known as early-onset ataxia with ocular motor apraxia and hypoalbuminemia, is a rare autosomal recessive disorder caused by mutations in the APTX gene.
Article text
AOA1 was first described by Aicardi and colleagues in 1988.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.